PT - JOURNAL ARTICLE AU - Kucikova, Ludmila AU - Zeng, Jianmin AU - Brass, Adam J. AU - Muñoz-Neira, Carlos AU - Ritchie, Craig W. AU - Muniz-Terrera, Graciela AU - O’Brien, John AU - Su, Li TI - Cognitively healthy young adults with <em>APOEe4</em> gene show disrupted functional connectivity of graph properties in multiple resting-state networks AID - 10.1101/2024.09.27.24314481 DP - 2024 Jan 01 TA - medRxiv PG - 2024.09.27.24314481 4099 - http://medrxiv.org/content/early/2024/09/28/2024.09.27.24314481.short 4100 - http://medrxiv.org/content/early/2024/09/28/2024.09.27.24314481.full AB - The apolipoprotein (APOE) e4 allele is associated with brain changes in healthy carriers that are similar to changes observed in patients with Alzheimer’s Disease, including abnormalities in functional connectivity. The trajectory of these changes across the lifespan, specifically in early adulthood is still not clear. This study explores the link between the APOE genotype and functional connectivity in 129 cognitively healthy Chinese Han college students (aged 17-22 years). By using graph theory, we assessed the connectivity in seven resting-state networks of interest using three different thresholding methods and three different forms of network parcellation. Average Path Length and Closeness Centrality were disrupted in e4 carriers in the sensorimotor, visual, salience, and Default Mode salience networks; with effects replicated using different thresholding but not different parcellation methods. This study demonstrated the genetics-related vulnerability in the brain of young APOEe4 carriers across multiple resting-state networks.Competing Interest StatementLK, JZ, AD, CMN, and GMT have no conflicts of interests to disclose. CR is the founder of Scottish Brain Sciences, and acted as a consultant for Biogen, Eisai, MSD, Actinogen, Roche, and Eli Lilly, and received payment or honoraria from Roche and Eisai in the past. JOB has acted as a consultant for TauRx, Novo Nordisk, Biogen, Roche, Lilly and GE Healthcare and received grant or academic support from Avid/ Lilly, Merck and Alliance Medical. LS acted as a consultant for Shenzhen MirrorEgo Technology Co. Ltd. This research was supported by the NIHR Sheffield Biomedical Research Centre (BRC) / NIHR Sheffield Clinical Research Facility (CRF). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care (DHSC).Funding StatementLK is the recipient of the Flagship Scholarship of the Neuroscience Institute, University of Sheffield. AJB was funded by the SURE Scholarship, University of Sheffield. LS was funded by Alzheimers Research UK Senior Research Fellowship (ARUK-SRF2017B-1), the Lewy Body Society (LS002/2019).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Southwest University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe anonymised data from the present study are available from the corresponding author on reasonable request.